Agios Reports Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Agios Pharma (AGIO) Tops Q4 EPS by 12c
February 13, 2020 7:23 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.60), $0.12 better than the analyst estimate of ($1.72). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $33.72 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More


